A federal panel moved every pending Cartiva implant lawsuit into one Arkansas courtroom on February 5, 2026. Three more case orders have followed since then. Here’s what changed, and what it means if you haven’t filed a claim yet.
Say you had a Cartiva Synthetic Cartilage Implant and later needed a revision surgery. The part that matters most right now is timing.
Filing late doesn’t cost you a place in the MDL. Timing does. A missed state deadline can cost you the right to file anything at all.
What Changed in the Cartiva MDL Since Last Year
Chief Judge Kristine G. Baker now oversees every federal Cartiva case in the Eastern District of Arkansas. One court sets the deadlines, the evidence rules, and the trial schedule now. Before, a dozen judges ran a dozen separate timelines.
Four dated actions built that outcome. Here’s the record, straight from the court’s own MDL 3172 page.
| Date | What happened |
|---|---|
| October 31, 2024 | Stryker issues a Class II recall covering all four Cartiva implant sizes distributed since July 2016 |
| January 2026 | The Judicial Panel on Multidistrict Litigation holds its hearing session on whether to consolidate the federal Cartiva cases |
| February 5, 2026 | The panel transfers every federal Cartiva case to the Eastern District of Arkansas as MDL No. 3172 |
| February 6, 2026 | The court enters Conditional Transfer Order CTO-1, routing new filings straight into the MDL |
| February 18, 2026 | The court enters its Order Upon Transfer, setting the first round of case-management rules |
None of this merges your case with anyone else’s. Consolidation means the evidence gathering happens once, in front of one judge, instead of separately in a dozen district courts. Your medical history and your losses still decide your claim on their own.
How Cartiva Ended Up in One Arkansas Courtroom
The panel picked Arkansas for a specific reason. The evidence trail runs through Memphis. Wright Medical Group, Cartiva’s corporate successor, was headquartered there. Much of the case’s paperwork and witnesses sit close to that city.
The corporate history matters to your claim, since liability can follow a company through a sale. Cartiva, Inc. built the implant and won FDA approval for it in 2016. Wright Medical bought Cartiva two years later, and Stryker bought Wright Medical in 2020 (three years before it issued the recall). Your attorney names the entities that controlled the device when you had your surgery.
Mass Tort MDL Versus Class Action, and Why It Changes Your Number
Say one woman needed two revision surgeries and missed 18 months of work. Say another patient’s implant is intact but was flagged early. A mass tort values those two claims differently. A class action barely tells them apart.
In a class action, one or two named plaintiffs represent the whole group. Everyone in the class tends to collect a similar, often modest, payout, no matter how severe their own injury was. A mass tort MDL runs on a different model. You file your own lawsuit, and you share the evidence-gathering process with every other plaintiff. Your outcome stays entirely your own, tied to your own facts.
Cartiva’s litigation is proceeding as a mass tort. That’s the better structure for patients with serious complications. The value of your claim comes from your own surgical record and your own losses. Thousands of other files don’t set your number.
What a Bellwether Trial Tests
Once an MDL reaches a certain size, the court picks a small number of cases to try first. Those early verdicts become the number every later settlement conversation gets measured against, including yours, even if your case is never one of the trials selected.
Judge Baker’s court is still in the early stage of that work for MDL 3172. Evidence-sharing and case-selection rules usually come first, before any trial date gets set. The February 18 order is the document that starts building those rules. No confirmed bellwether date exists yet on the court’s own docket. A few individual cases had trial dates set before they transferred into the MDL, but those aren’t the same as an MDL bellwether date, so treat any specific 2026 date you read elsewhere with caution.
The Recall, the 13.5 Percent Figure, and What Independent Data Shows
Stryker’s recall notice, dated October 31, 2024, covers every Cartiva implant distributed since July 2016. The company’s own safety notice says complications happened more often than the data it gave the FDA had predicted.
That original FDA filing leaned on the MOTION clinical trial, a study of just 152 procedures that reported a 13.5 percent failure rate. Plaintiffs argue that figure never held up once thousands of ordinary patients, far more than the small trial group, received the implant. Most of those patients weren’t in any trial. They got the implant after Stryker had already brought it to market.
One figure holds up under direct sourcing. A 2024 study by Radcliffe and Roukis looked at 236 adverse-event reports filed against the Cartiva implant in the FDA’s MAUDE database. The study ran in the journal Foot & Ankle Surgery: Techniques, Reports and Cases. The analysis found implant removal in 73.7 percent of those reported cases, a peer-reviewed-adjacent figure tied to a named study.
A recall doesn’t prove legal liability on its own, and it isn’t required for a valid claim. But it’s a public record your attorney can build from instead of starting cold with your surgical file.
Baker Legal Team covered the recall as it happened, in our press release on the Cartiva MDL and recall.
Can You Still File a Cartiva Lawsuit
Yes, in most cases. New Cartiva lawsuits are still being filed and transferred into the MDL every month.
Your filing window depends on your state’s statute of limitations, and that clock doesn’t start the same way everywhere. Some states run it from your surgery date. Many states use a discovery rule instead. That rule starts the clock on the date you reasonably found out about the link between the implant and your injury.
The recall date on its own doesn’t reset anyone’s deadline. Whether the discovery rule helps your timeline depends on where you live and where your surgery happened. A free case review answers that question directly, instead of leaving you to guess.
Three Things Baker Legal Team Confirms Before Taking a Cartiva Case
- You received a Cartiva implant. The device was implanted for hallux rigidus or hallux limitus, forms of big-toe arthritis, between July 2016 and the October 2024 recall.
- You experienced complications. Ongoing pain, swelling, stiffness, trouble walking, implant migration, or bone loss after the procedure (even years later).
- You needed a follow-up procedure. Revision surgery, removal, conversion to fusion, or another corrective step tied to the implant’s failure.
Not sure of your surgery date or which records you have? That’s a normal starting point. A case review helps confirm the details through your own medical records.
Why a Board Certified Trial Lawyer Is Running This Practice
Robert B. Baker holds Board Certification in Civil Trial from the Florida Bar. Fewer than one percent of Florida attorneys hold that credential. He reviews every Cartiva case his firm accepts personally.
His background with cases like this goes back further than most attorneys now entering the Cartiva MDL. From 1993 to 1994, Robert served as Rhode Island’s State Liaison Counsel for the multidistrict breast implant cases. He coordinated claims against Dow for people across Massachusetts and Rhode Island. Cartiva’s MDL runs on nearly the same setup today. One lead court, shared evidence, and claims that rise or fall on their own facts. Baker Legal Team also handles other active mass tort cases right now, including the Dupixent lawsuit.
Answers to the Most Asked Questions About the Cartiva MDL
Do I need an existing lawsuit to join the MDL?
No. Most patients now part of the litigation are filing for the first time, directly into the federal court overseeing MDL 3172.
Does it hurt my case if my symptoms started before the October 2024 recall?
Not at all. The recall date doesn’t define who qualifies. What matters is whether you received the implant, experienced complications, and needed a follow-up procedure, regardless of when your symptoms began.
Will bellwether trials happen before I can file?
Filing and the trial schedule run on two separate tracks. Waiting for a trial date before you submit your case for review only shortens the time your attorney has to build your file.
What if I already reached a settlement directly with Stryker or a hospital?
That depends heavily on what you signed. A free case review can tell you whether a prior agreement affects your options now.
How long does a Cartiva case usually take?
Most mass tort cases run one to three years from filing to resolution. The MDL tends to move faster than the same cases would move through a dozen separate state courts. Your own timeline still depends on when you filed and where your case falls relative to the bellwether cases.
What Filing Now Buys You Before the Bellwether Results Land
Filing now preserves your place in the litigation and gives your attorney real time to gather your medical records. That file gets built before the first verdicts land, while other claimants are still scrambling to catch up.
You don’t need to become an expert in multidistrict litigation. You need an attorney who has coordinated mass tort claims before and holds the credentials to prove it. That attorney should review your file personally instead of handing it off to whoever’s queue is shortest that week.
Start your free Cartiva case review or call 800-920-0002. No fees and no costs unless we recover. Baker Legal Team will keep publishing Cartiva updates as MDL 3172 moves forward.
Sources. U.S. Judicial Panel on Multidistrict Litigation, Transfer Order, MDL No. 3172 (Feb. 5, 2026); U.S. District Court for the Eastern District of Arkansas, MDL 3172 case docket page, Case No. 4:26-md-03172-KGB; Stryker, Urgent Medical Device Recall notice (Oct. 31, 2024); U.S. Food and Drug Administration, Class 2 Device Recall record; Radcliffe MJ, Roukis TS, “A review of adverse events related to synthetic cartilage implant for the first metatarsophalangeal joint,” Foot & Ankle Surgery: Techniques, Reports and Cases (2024).